Sequential therapies with sorafenib and sunitinib in advanced or metastatic renal cell carcinoma

Edwin Herrmann,Norbert Marschner,Marc-Oliver Grimm,C. H. Ohlmann,Ulrich Hutzschenreuter,Friedrich Overkamp,M. Groschek,K. Blumenstengel,G. Pühse,Thomas Steiner

Sequential therapies with sorafenib and sunitinib in advanced or metastatic renal cell carcinoma

2011

Edwin Herrmann
Norbert Marschner
Marc-Oliver Grimm
C. H. Ohlmann
Ulrich Hutzschenreuter
Friedrich Overkamp
M. Groschek
K. Blumenstengel
G. Pühse
Thomas Steiner

Purpose To investigate whether patients with metastatic renal cell carcinoma benefit from sequential therapies with the tyrosine kinase inhibitors (TKIs) sorafenib and sunitinib.

Keywords:

Carcinoma
Progression-free survival
Pathology
Tyrosine-kinase inhibitor
Sorafenib
Internal medicine
Kidney cancer
Sunitinib
Medicine
Renal cell carcinoma
Nephrology
Cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations